Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Safety of binodenoson, a selective adenosine A2A receptor agonist vasodilator pharmacological stress agent, in healthy subjects with mild intermittent asthma.

Murray JJ, Weiler JM, Schwartz LB, Busse WW, Katial RK, Lockey RF, McFadden ER Jr, Pixton GC, Barrett RJ.

Circ Cardiovasc Imaging. 2009 Nov;2(6):492-8. doi: 10.1161/CIRCIMAGING.108.817932. Epub 2009 Sep 17.

2.

Randomized, controlled dose-ranging study of the selective adenosine A2A receptor agonist binodenoson for pharmacological stress as an adjunct to myocardial perfusion imaging.

Udelson JE, Heller GV, Wackers FJ, Chai A, Hinchman D, Coleman PS, Dilsizian V, DiCarli M, Hachamovitch R, Johnson JR, Barrett RJ, Gibbons RJ.

Circulation. 2004 Feb 3;109(4):457-64. Epub 2004 Jan 20.

3.

Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: a randomized, double-blind, placebo-controlled trial.

Leaker BR, O'Connor B, Hansel TT, Barnes PJ, Meng L, Mathur VS, Lieu HD.

J Nucl Cardiol. 2008 May-Jun;15(3):329-36. doi: 10.1016/j.nuclcard.2008.02.009. Epub 2008 Apr 14.

PMID:
18513639
4.

Coronary circulation responses to binodenoson, a selective adenosine A2A receptor agonist.

Hodgson JM, Dib N, Kern MJ, Bach RG, Barrett RJ.

Am J Cardiol. 2007 Jun 1;99(11):1507-12. Epub 2007 Apr 16.

PMID:
17531571
5.

Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers.

Barrett RJ, Lamson MJ, Johnson J, Smith WB.

J Nucl Cardiol. 2005 Mar-Apr;12(2):166-71.

PMID:
15812370
6.

Effect of ticagrelor on pulmonary function in healthy elderly volunteers and asthma or chronic obstructive pulmonary disease patients.

Butler K, Maya J, Teng R.

Curr Med Res Opin. 2013 May;29(5):569-77. doi: 10.1185/03007995.2013.781502. Epub 2013 Apr 2.

PMID:
23448616
7.

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.

PMID:
18211118
9.

Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men.

van Troostenburg AR, Clark EV, Carey WD, Warrington SJ, Kerns WD, Cohn I, Silverman MH, Bar-Yehuda S, Fong KL, Fishman P.

Int J Clin Pharmacol Ther. 2004 Oct;42(10):534-42.

PMID:
15516022
10.

Side effect profile and tolerability of adenosine myocardial perfusion scintigraphy in patients with mild asthma or chronic obstructive pulmonary disease.

Reyes E, Loong CY, Wechalekar K, Latus K, Anagnostopoulos C, Underwood SR.

J Nucl Cardiol. 2007 Nov-Dec;14(6):827-34. Epub 2007 Oct 18.

PMID:
18022109
11.

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease.

Prenner BM, Bukofzer S, Behm S, Feaheny K, McNutt BE.

J Nucl Cardiol. 2012 Aug;19(4):681-92. doi: 10.1007/s12350-012-9547-4. Epub 2012 Apr 7.

12.
13.

A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.

Gordi T, Frohna P, Sun HL, Wolff A, Belardinelli L, Lieu H.

Clin Pharmacokinet. 2006;45(12):1201-12.

PMID:
17112296
14.

Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction.

Leff JA, Busse WW, Pearlman D, Bronsky EA, Kemp J, Hendeles L, Dockhorn R, Kundu S, Zhang J, Seidenberg BC, Reiss TF.

N Engl J Med. 1998 Jul 16;339(3):147-52.

15.

The actions of dopamine on the airways.

Cabezas GA, Israili ZH, Velasco M.

Am J Ther. 2003 Nov-Dec;10(6):477-86.

PMID:
14624291
16.

Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, double-blind, placebo-controlled trial (RegCOPD trial).

Thomas GS, Tammelin BR, Schiffman GL, Marquez R, Rice DL, Milikien D, Mathur V.

J Nucl Cardiol. 2008 May-Jun;15(3):319-28. doi: 10.1016/j.nuclcard.2008.02.013. Epub 2008 Apr 14.

PMID:
18513638
17.

[Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].

Wang HY, Lin XP, Hao CL, Zhang CQ, Sun BQ, Zheng JP, Chen P, Sheng JY, Wu A, Zhong NS.

Zhonghua Jie He He Hu Xi Za Zhi. 2006 Oct;29(10):679-87. Chinese.

PMID:
17129496
19.

Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.

Blake K, Pearlman DS, Scott C, Wang Y, Stahl E, Arledge T.

Ann Allergy Asthma Immunol. 1999 Feb;82(2):205-11.

PMID:
10071526
20.
Items per page

Supplemental Content

Write to the Help Desk